劑量計市場 - 2026-2031年預測

預計劑量計市場將從 2025 年的 30.04 億美元成長到 2031 年的 43.09 億美元，複合年成長率為 6.2%。

劑量計——用於測量累積或即時電離輻射暴露量的裝置——已成為醫療、核能、工業射線照相和國防應用領域不可或缺的安全工具。現代產品系列涵蓋了從被動式積分技術（光釋光劑量計、熱釋光劑量計、膠片）到具有直接讀數、警報功能和無線遙測功能的主動式電子個人劑量計（EPD）等多種類型。目前，領先的系統在1微西弗至10西弗的範圍內可實現±10%的精度，而將法定記錄功能與即時反饋相結合的混合型光釋光/電子個人劑量計正日益普及。

醫療輻射防護領域仍是規模最大且成長最快的領域。 CT、介入螢光和影像導航放射治療在全球範圍內的廣泛應用，顯著增加了放射科醫生、心臟科醫生、腫瘤科醫生和技術人員的職業輻射計量。監管劑量限值（五年平均每年20毫希沃特，單年50毫希沃特，適用於大多數司法管轄區）和ALARA原則要求在A類工作人員閾值以上的醫療機構中實施個人劑量監測。同時，歐盟指令2013/59/Euratom、醫療機構聯合委員會（JCAHO）標準以及類似框架下的病患劑量追蹤要求，正在推動醫療機構廣泛採用區域監測和診斷參考水準（DRL）監測解決方案。

核能是第二大支柱。中國、印度和韓國的在運作中核電廠，以及中東歐新興的核能發電廠項目，持續推進建設，從而對符合IEC 61526和ANSI N13.27標準的、性能可靠且靈敏度高的環境輻射檢測器（EPD）產生了持續的需求。歐洲和北美地區的退役和廢棄物管理活動也進一步推動了對具備污染反應能力和中子靈敏度的設備的長期需求。

亞太地區正崛起為強勁的成長引擎。中國承諾在2050年新建150多座核子反應爐，印度計畫擴建22座反應堆，韓國正在興建的APR-1400反應器，這些計畫的產能擴張規模總和遠遠超過其他任何地區。同時，對先進醫療影像設備（特別是直線加速器和PET/CT掃描儀）的投資，正在形成區域協同效應。政府針對國內放射治療和核子醫學掃描術診斷設備製造生產連結獎勵計畫，進一步刺激了當地對符合標準的劑量測定系統的需求。

技術演進圍繞著四個性能指標：

1. 無線連接：藍牙/BLE 和 LoRa 網路，用於即時集中劑量管理和地理圍欄警報。

2. 混合 OSL + 矽檢測器設計：提供即時讀數和劑量率測量，同時維持法定劑量精度。

3. 中子和混合場能力，配備高濃縮 6Li/7Li TLD 對和小氣泡檢測器（適用於先進反應器環境）。

4. 基於雲端的劑量管理軟體，整合了設施存取控制、訓練記錄和預測輻射暴露預測。

競爭環境有利於那些將硬體與認證劑量測定服務相結合的製造商（例如 Landauer、Mirion、Thermo Fisher、Fuji Electric 和 Chiyoda Technol）。純硬體製造商由於中國製造商提供低成本被動式 OSL 閱讀器而面臨利潤率壓力，而精密主動式 EPD 的利潤率則受到嚴格的核能認證標準（例如 10CFR35、IEC 60846-1 和 ANSI N42.20）的保護。

監管協調工作正在推進，實施速度也正在加快。國際原子能總署安全標準RS-G-1.1/1.3和國際放射性核種測量委員會/國際放射防護委員會建議的修訂提案持續收緊職業暴露限值，並擴大強制監測範圍。各國計畫（如中國國家國防科技工業局、印度美國核能管理委員會、韓國核能安委員會）正日益與西方標準接軌，在全部區域形成統一的需求模式。

供應限制仍然較小，但主要集中在高純度Al₂O₃:C和BeO OSL晶體以及中子級⁶LiF檢測器，這些領域的全球認證產能僅限於少數專業工廠。在建設高峰期，獲得完全符合IEC 61526第三版認證的核能級EPD（環境性能聲明）的前置作業時間可能長達12-18個月。

對於輻射安全和設施管理人員而言，鑑於主動式系統能夠減輕管理負擔、即時預防輻射暴露並消除劑量計丟失事件，總體擁有成本模型如今通常足以證明其合理性。將個人、區域和患者劑量測定功能整合到單一供應商軟體平台上的方案將帶來最大的效率提升。

總體而言，劑量計在結構上佔據有利地位，這得益於全球兩大輻射暴露成長最快的領域（先進醫學影像和新建核能發電廠）中強制性的監管要求、清晰的技術藍圖（該路線圖正在擴大劑量計與傳統膠片/熱釋光劑量計的性能差距）以及高認證門檻對現有企業的保護。將經認證的劑量測定服務與下一代無線/混合硬體和雲端分析相結合的公司，預計將在這個受監管主導的安全領域保持兩位數的成長和強勁的利潤率。

本報告的主要優勢：

• 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
• 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
• 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
• 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
• 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及影響、新產品開發、競爭影響

分析範圍

• 歷史資料（2021-2025 年）和預測資料（2026-2031 年）
• 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
• 競爭對手定位、策略和市場佔有率分析
• 按業務板塊和地區（國家）分類的收入成長和預測分析
• 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

• 市場概覽
• 市場定義
• 分析範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策和法規
• 策略建議

第4章 技術展望

第5章 按類型分類的劑量計市場

• 介紹
• 膠卷劑量計
• 熱釋光劑量計
• 電子個人劑量計
• 其他

第6章 輻射劑量計市場

• 介紹
• 阿爾法射線
• BETA射線
• 伽瑪射線

第7章 按最終用戶分類的劑量計市場

• 介紹
• 能源與電力
• 衛生保健
• 石油和天然氣
• 礦業
• 其他

第8章 各地區劑量計市場

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第9章：競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 企業合併、協議、商業合作
• 競爭對手儀錶板

第10章：公司簡介

• Arrow-Tech Inc.
• Fuji Electric Co., Ltd.
• IBA Dosimetry（Ion Beam Applications）
• Mirion Technologies, Inc.
• PTW Dosimetry
• Radiation Detection Company
• Thermo Fisher Scientific Inc.
• UAB Polimaster

第11章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 分析方法
• 簡稱

Dosimeter Market, at a 6.2% CAGR, is projected to increase from USD 3.004 billion in 2025 to USD 4.309 billion in 2031.

Dosimeters-devices designed to measure cumulative or real-time exposure to ionizing radiation-have become indispensable safety tools across medical, nuclear energy, industrial radiography, and defense applications. Modern portfolios span passive integrating technologies (OSL, TLD, film) and active electronic personal dosimeters (EPDs) with direct-reading, alarming, and wireless telemetry capabilities. Leading systems now achieve +-10 % accuracy across 1 µSv-10 Sv ranges, with hybrid OSL/EPD units gaining traction for their combination of legal record-keeping and instant feedback.

Medical radiation protection remains the largest and fastest-growing segment. The global proliferation of CT, interventional fluoroscopy, and image-guided radiotherapy has dramatically increased occupational doses for radiologists, cardiologists, oncologists, and technologists. Regulatory dose limits (20 mSv/yr averaged over 5 years, 50 mSv single year in most jurisdictions) and ALARA principles drive mandatory personal monitoring in any facility exceeding Class A worker thresholds. Simultaneously, patient-dose tracking requirements under EU 2013/59/Euratom, U.S. Joint Commission standards, and similar frameworks are expanding institutional adoption of area and diagnostic reference level (DRL) monitoring solutions.

Nuclear energy represents the second major pillar. Operational fleets in China, India, South Korea, and emerging programs in the Middle East and Eastern Europe continue aggressive construction schedules, creating sustained demand for rugged, high-range EPDs certified to IEC 61526 and ANSI N13.27 standards. Decommissioning and waste-management activities in Europe and North America further amplify long-term requirements for contamination-capable and neutron-sensitive devices.

Asia-Pacific has emerged as the clear growth engine. China's commitment to 150+ new reactors by mid-century, India's 22-unit expansion pipeline, and South Korea's continued APR-1400 build-out collectively dwarf capacity additions elsewhere. Parallel investment in advanced medical imaging-particularly linear accelerators and PET/CT installations-creates a compounding regional effect. Government production-linked incentives for domestic radiotherapy and nuclear-imaging equipment manufacturing further accelerate local demand for compliant dosimetry systems.

Technology evolution centers on four performance vectors:

1. Wireless connectivity-Bluetooth/BLE and LoRa networks enabling real-time centralized dose management and geofencing alarms.

2. Hybrid OSL + silicon detector designs offering legal dosimetry accuracy with instantaneous readout and rate metering.

3. Neutron and mixed-field capability via enriched 6Li/7Li TLD pairs and miniature bubble detectors for advanced reactor environments.

4. Cloud-based dose-management software integrating facility access control, training records, and predictive exposure forecasting.

Competitive dynamics favor manufacturers that bundle hardware with accredited dosimetry services (Landauer, Mirion, Thermo Fisher, Fuji Electric, Chiyoda Technol). Pure hardware players face margin pressure from Chinese entrants offering low-cost passive OSL readers, while premium active EPD margins remain protected by stringent nuclear certification barriers (10CFR35, IEC 60846-1, ANSI N42.20).

Regulatory harmonization is accelerating adoption. IAEA Safety Standards RS-G-1.1/1.3 and forthcoming revisions to ICRU/ICRP recommendations continue to tighten occupational limits and expand mandatory monitoring categories. National programs-China's State Administration of Science, Technology and Industry for National Defense (SASTIND), India's Atomic Energy Regulatory Board (AERB), and Korea's Nuclear Safety and Security Commission (NSSC)-are aligning ever closer with Western benchmarks, creating uniform regional demand profiles.

Supply constraints remain modest but center on high-purity Al2O3:C and BeO OSL crystals, plus neutron-grade 6LiF detectors, where qualified global capacity is limited to a handful of specialized facilities. Lead times for nuclear-grade EPDs with full IEC 61526 Ed.3 certification can extend 12-18 months during construction peaks.

For radiation safety officers and facility managers, total-cost-of-ownership models now routinely justify premium active systems when factoring reduced administrative burden, real-time exposure prevention, and elimination of lost-badge events. Programs that integrate personal, area, and patient dosimetry under single-vendor software platforms capture the largest efficiency gains.

Overall, dosimeters occupy a structurally advantaged position: non-discretionary regulatory requirement in the world's two fastest-growing radiation-exposure sectors (advanced medical imaging and new-build nuclear), clear technology roadmaps that widen performance gaps versus legacy film/TLD, and high certification barriers that protect incumbents. Companies combining accredited dosimetry services with next-generation wireless/hybrid hardware and cloud analytics are positioned for sustained double-digit growth and resilient margins in this essential, regulation-driven safety category.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Segmentation:

• By Type
• Film Badge Dosimeter
• Thermoluminescent Dosimeter
• Electronic Personal Dosimeter
• Others
• By Radiation
• Alpha
• Beta
• Gamma
• By End-User
• Energy and Power
• Healthcare
• Oil & Gas
• Mining
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. DOSIMETER MARKET BY TYPE

• 5.1. Introduction
• 5.2. Film Badge Dosimeter
• 5.3. Thermoluminescent Dosimeter
• 5.4. Electronic Personal Dosimeter
• 5.5. Others

6. DOSIMETER MARKET BY RADIATION

• 6.1. Introduction
• 6.2. Alpha
• 6.3. Beta
• 6.4. Gamma

7. DOSIMETER MARKET BY END-USER

• 7.1. Introduction
• 7.2. Energy and Power
• 7.3. Healthcare
• 7.4. Oil & Gas
• 7.5. Mining
• 7.6. Others

8. DOSIMETER MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Arrow-Tech Inc.
• 10.2. Fuji Electric Co., Ltd.
• 10.3. IBA Dosimetry (Ion Beam Applications)
• 10.4. Mirion Technologies, Inc.
• 10.5. PTW Dosimetry
• 10.6. Radiation Detection Company
• 10.7. Thermo Fisher Scientific Inc.
• 10.8. UAB Polimaster

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations